Search Results 81-90 of 17367 for direct bilirubin

  1. Study Evaluating the Safety, Tolerability, and Effectiveness of EDP-305 in Subjects with Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    NOTE: Patients with Gilbert's syndrome will be allowed if they have a known history of Gilbert's syndrome with a normal direct bilirubin value and normal ...

  2. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

    Total bilirubin < 2.0 X ULN (unless active hemolysis); for subjects with Gilbert's Syndrome, direct bilirubin < 1.5 X ULN. Patients with known infection ...

  3. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must be normal; Alkaline (Alk.) phosphatase ...

  4. A Study to Evaluate Ribociclib Plus Letrozole to Treat Cancer of the Ovary, Fallopian Tube or Peritoneum - Mayo Clinic

    Total bilirubin < ULN or total bilirubin ≤ 3.0 x ULN or direct bilirubin ≤ 1.5 x ULN in patients with well-documented Gilbert's Syndrome. Patient with ...

  5. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    ... bilirubin is ≤ 3.0 × ULN or direct bilirubin ≤ 1.5 × ULN;; In absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase ...

  6. A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

    Total bilirubin < ULN; or total bilirubin ≤ 3 .0 x ULN or direct bilirubin ≤ 1.5 x ULN in patients with well-documented Gilbert's Syndrome. Sexually ...

  7. A Study to Evaluate Infigratinib to Treat Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302) - Mayo Clinic

    Total bilirubin > 1.5 × upper limit of normal (ULN) of the testing laboratory (for subjects with documented Gilbert syndrome, direct bilirubin must be ...

  8. Study to Compare the Safety and Effectiveness of Treatment Combinations in Patients with Recurrent Ovarian Cancer - Mayo Clinic

    Patients with Gilbert's syndrome may enroll if direct bilirubin is ≤ .5 × ULN for the direct bilirubin;; Aspartate aminotransferase and alanine ...

  9. A Study of the Safety, Tolerability, and Effectiveness of GS-9674 for Adults with Primary Sclerosing Cholangitis without Cirrhosis - Mayo Clinic

    ... direct bilirubin instead of total bilirubin. Exclusion Criteria. Alanine aminotransferase (ALT) > 10 x ULN; Total bilirubin > 2 x ULN; International normalized ...

  10. A Study to Evaluate ION251 to Treat Patients with Relapsed/Refractory Multiple Myleoma - Mayo Clinic

    Total bilirubin > 1.3 × ULN (patients with Gilbert's Syndrome may be eligible if direct bilirubin < 1 × ULN and results reviewed with the Medical Monitor); ...